Arendals Fossekompani ASA (OSL:AFK)

Orchard Therapeutics Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,444	7,823	9,035	13,751	24,425	10,097
Market Cap Growth	-31.77%	-13.41%	-34.30%	-43.70%	141.91%	75.35%
Enterprise Value	7,764	9,270	10,116	13,489	23,906	9,921
Last Close Price	135.50	140.22	158.36	235.30	409.08	150.31
PE Ratio	3.36	3.50	277.23	2394.03	228.90	163.07
PS Ratio	1.75	1.81	2.33	3.01	5.78	3.26
PB Ratio	1.40	1.45	2.48	3.63	6.25	2.62
P/TBV Ratio	1.82	1.81	7.63	7.87	9.72	3.90
P/FCF Ratio	55.36	29.36	-	211.69	40.42	-
P/OCF Ratio	13.85	10.52	-	32.48	28.49	74.78
EV/Sales Ratio	1.82	2.15	2.61	2.95	5.65	3.20
EV/EBITDA Ratio	9.98	11.64	16.61	22.00	41.45	31.80
EV/EBIT Ratio	24.64	24.73	22.41	29.05	52.22	55.92
EV/FCF Ratio	57.74	34.79	-	207.66	39.56	-
Debt / Equity Ratio	0.34	0.34	0.81	0.37	0.28	0.36
Debt / EBITDA Ratio	2.25	2.10	4.27	2.02	1.72	3.65
Debt / FCF Ratio	13.33	6.91	-	21.46	1.84	-
Asset Turnover	0.47	0.48	0.46	0.62	0.61	0.47
Inventory Turnover	1.76	1.85	1.44	2.21	2.76	1.90
Quick Ratio	1.61	1.56	1.25	1.28	1.92	1.37
Current Ratio	2.07	2.03	1.75	1.59	2.19	1.90
Return on Equity (ROE)	-1.81%	-0.94%	1.65%	-0.84%	2.50%	1.83%
Return on Assets (ROA)	2.31%	2.62%	3.34%	3.95%	4.14%	1.69%
Return on Capital (ROIC)	3.02%	3.39%	4.80%	5.69%	5.58%	2.26%
Return on Capital Employed (ROCE)	4.90%	5.30%	7.20%	9.40%	9.50%	3.90%
Earnings Yield	29.76%	28.60%	0.36%	0.04%	0.44%	0.61%
FCF Yield	1.81%	3.41%	-11.58%	0.47%	2.47%	-0.68%
Dividend Yield	2.95%	2.85%	2.53%	1.62%	0.82%	1.26%
Payout Ratio	11.39%	11.19%	770.71%	4013.65%	1684.86%	378.80%
Buyback Yield / Dilution	-0.14%	-0.12%	0.03%	0.07%	-0.05%	-0.40%
Total Shareholder Return	2.66%	2.73%	2.56%	1.69%	0.77%	0.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.